Immediate Impact
9 standout
Citing Papers
G protein-coupled receptors (GPCRs): advances in structures, mechanisms and drug discovery
2024 Standout
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
2024 Standout
Works of Patrick J. O’Hearn being referenced
Abstract 1455: RLY-4008, a novel precision therapy for FGFR2-driven cancers designed to potently and selectively inhibit FGFR2 and FGFR2 resistance mutations
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Patrick J. O’Hearn | 13 | 6 | 5 | 2 | 18 | ||
| Ellice Marwood | 12 | 6 | 9 | 2 | 19 | ||
| Danielle Pasternack | 11 | 3 | 3 | 2 | 17 | ||
| Jitlada Juengsamarn | 6 | 6 | 6 | 3 | 21 | ||
| Simon Imm | 8 | 3 | 4 | 2 | 16 | ||
| Francesca Rocchetti | 11 | 7 | 1 | 4 | 3 | 18 | |
| Mark P.G. Dings | 12 | 8 | 2 | 3 | 16 | ||
| Caleb Choo | 11 | 8 | 2 | 2 | 19 | ||
| Yanjuan Ma | 13 | 3 | 3 | 3 | 17 | ||
| Catherine Tolman | 12 | 8 | 2 | 2 | 22 | ||
| Ines Vermeire | 14 | 7 | 2 | 2 | 24 |
All Works
Login with ORCID to disown or claim papers
Loading papers...